Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Posted on August 19, 2024 by Vaseline

BOSTON, Aug. 19, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics
to selectively engage and modulate disease-specific T cells, provided a business and financial update for the second quarter 2024.

Recent Business Highlights

Related Posts

God of War Ragnarök: PC version experience Review-Bombing

“Axiom” at ARD nochmal sehen: Wiederholung online and on TV

Wurmbrand goal at Debüt reicht nicht: Rapid play 1:1 at WAC – Bundesliga